Form 8-K - Current report:
SEC Accession No. 0001140361-24-009040
Filing Date
2024-02-22
Accepted
2024-02-22 16:15:35
Documents
22
Period of Report
2024-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ef20022028_8k.htm   iXBRL 8-K 78010
2 UNDERWRITING AGREEMENT ef20022028_ex1-1.htm EX-1.1 584882
3 FOURTEENTH SUPPLEMENTAL INDENTURE ef20022028_ex4-1.htm EX-4.1 717200
4 OPINION OF KIRKLAND & ELLIS LLP ef20022028_ex5-1.htm EX-5.1 21375
9 image0.jpg GRAPHIC 65135
10 image00001.jpg GRAPHIC 22861
11 image1.jpg GRAPHIC 43831
12 image00002.jpg GRAPHIC 3866
  Complete submission text file 0001140361-24-009040.txt   1992499

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmy-20240214.xsd EX-101.SCH 4697
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20240214_def.xml EX-101.DEF 18375
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20240214_lab.xml EX-101.LAB 28470
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20240214_pre.xml EX-101.PRE 20674
23 EXTRACTED XBRL INSTANCE DOCUMENT ef20022028_8k_htm.xml XML 8285
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 24664983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)